The safety of specific immunotherapy for patients allergic to house-dust mites and pollen in relation to the development of neoplasia and autoimmune disease: A long-term, observational case-control study

International Archives of Allergy and Immunology

Volumn 163, Issue 4, 2014, Pages 307-312

  Bozek, Andrzej ^a   Kozłowska, Renata ^b   Jarzab, Jerzy ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Hospital Bonifratów   (Poland)

Author keywords

Allergic rhinitis; Asthma; Autoimmune disease; Cancer; Specific immunotherapy

Indexed keywords

ANTINUCLEAR ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; HOUSE DUST ALLERGEN; POLLEN ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALBINISM; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; BREAST CANCER; CASE CONTROL STUDY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HASHIMOTO DISEASE; HODGKIN DISEASE; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; LUNG CANCER; LUPUS ERYTHEMATOSUS; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OBSERVATIONAL STUDY; OVARY CANCER; PALLIATIVE THERAPY; PANCREAS CANCER; PATIENT SAFETY; POLLEN ALLERGY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CARCINOMA; SJOEGREN SYNDROME; SKIN CANCER; SPECIFIC IMMUNOTHERAPY; STOMACH CANCER; SYSTEMIC VASCULITIS; THYROID CANCER; TREATMENT DURATION; ULCERATIVE COLITIS; UTERINE CERVIX CANCER; UTERUS CANCER; CARCINOGENESIS; CLINICAL EVALUATION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG SAFETY; DRUG SCREENING; HAY FEVER; NONHODGKIN LYMPHOMA; PERENNIAL RHINITIS;

ADULT; ALLERGENS; ANIMALS; ASTHMA; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOTHERAPY; INCIDENCE; MALE; NEOPLASMS; POLLEN; PYROGLYPHIDAE; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

EID: 84899594383     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000361022     Document Type: Article

References (21)

1. Passalacqua G, Canonica GW: Specific immunotherapy in asthma: efficacy and safety. Clin Exp Allergy 2011; 41: 1247-1255.
2. Iglesias-Cadarso A, Hernandez-Weigand P: Risk factors for systemic reactions to allergen immunotherapy 2011; 11: 579-585.
3. Linneberg A, Jacobsen RK, Jespersen L, Abildstrom SZ: Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischaemic heart disease, and mortality. J Allergy Clin Immunol 2012; 129: 413-419.
4. Turner MC, Chen Y, Krewski D, Ghardian P: An overview of the association between allergy and cancer. Int J Cancer 2006; 118: 124-132.
5. Jacobsen L, Valovirta E: How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma? Curr Opin Allergy Clin Immunol 2007; 7: 556-560.
6. Calderon MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P: Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol 2011; 127: 30-38.
7. http://apps.who.int/classifications/icd10/ browse/2010/en (available 12.01.2010).
8. Janson C, Anto J, Burney P, Chin S, de Marco R, Heinrich J, Jarvis D, Kuenzli N, Leynaert B, Luczynska C, Neukirch F, Svnaes C, Sunyer J, Wjst M: The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001; 18: 598-611.
9. Brusasco V, Crapo R, Viegi G; American Thoracic Society; European Respiratory Society: Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J 2005; 26: 153-161.
10. Global Initiative for Asthma: GINA report. Global Strategy for Asthma Management and Prevention 2008. http://www.ginasthma.org.
11. Linabery AM, Jurek AM, Duval S, Ross JA: The association between atopy and childhood/ adolescent leukemia: a meta-analysis. Am J Epidemiol 2010; 171: 749-764.
12. Turner MC, Chen Y, Krweski D, Ghadirian P: An overview of the association between allergy and cancer. Int J Cancer 2006; 118: 3124-3132.
13. Lindelof B, Granath F, Tengvall-Linder M, Ekbom A: Allergy 2005; 60: 1116-1120.
14. Wang H, Diepgen TL: Is atopy a protective or a risk factor for cancer/a review of epidemiological studies. Allergy 2005; 60: 1098-1111.
15. Fujita H, Soyka MB, Akadis M, Akadis CA: Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy 2012; 2: 2.
16. Sequeira JF, Cesic D, Keser G, Bukelica M, Karanagnotis S, Khamashta MA, Hughes GR: Allergic disorders in systemic lupus erythematosus. Lupus 1993; 2: 187-191.
17. Taylor RJ: Hypersensitivity vasculitis occurring in a patient receiving immunotherapy. J Allergy Clin Immunol 1991; 87: 889-890.
18. Maciel BM, Morfin BM: Specific immunotherapy-related scleroderma. Case report. Rev Alerg Mex 2009; 56: 135-144.
19. Turkcapar N, Kinikli G, Sak SD, Duman M: Specific immunotherapy-induced Sjogren's syndrome. Rheumatol Int 2005; 26: 182-184.
20. Yukselen A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB: Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study. Int Arch Allergy Immunol 2012; 157: 288-298.
21. Pevec B, Radulovic Pevec M, Stipic Markovic A, Batista I, Rijavec M, Silar M, Kosnik M, Korosec P: House dust mite-specific immunotherapy alters the basal expression of T regulatory and Fc RI pathway genes. Int Arch Allergy Immunol 2012; 159: 287-296.